| 摘要 |
FIELD: medicine.SUBSTANCE: nutrient medium contains pancreatic hydrolysate of casein, enzymatic peptone, enzymatic hydrolysate of black albumin, yeast extract, potassium dihydrogen phosphate, sodium chloride, soluble starch, microbiological agar and lyophilised growth additive No.1 and No.2 in the pre-set proportions of the ingredients. The growth additive No.1 contains adenine, vitamin B, calcium pantothenate, thiamine chloride, cocarboxylase, nicotin-amide-adenine-dinucleotide (NAD), ferric nitrate, L-glutamine, L-cysteine hydrochloride, R-aminobenzoic acid, polyvinylpyrrolidone and maltodextrine Glucidex 19; the growth additive No. 2 contains baker's yeast autolyzate, nicotin-amide-adenine-dinucleotide (NAD), polyvinylpyrrolidone or maltodextrine Glucidex 19 in the pre-set proportions of the ingredients.EFFECT: invention enables producing the nutrient medium possessing high sensitivity to purulent bacterial meningitis agents and enabling their stable growth.1 tbl, 2 ex |
